Literature DB >> 21183213

Polymer-related off-target effects in non-viral siRNA delivery.

Olivia M Merkel1, Andrea Beyerle, Benedikt M Beckmann, Mengyao Zheng, Roland K Hartmann, Tobias Stöger, Thomas H Kissel.   

Abstract

Since off-target effects in non-viral siRNA delivery are quite common but not well understood, in this study various polymer-related effects observed in transfection studies were described and their mechanisms of toxicity were investigated. A variety of stably luciferase-expressing cell lines was compared concerning polymer-mediated effects after transfection with polyplexes of siRNA and poly(ethylene imine) (PEI) or poly(ethylene glycol)-grafted PEI (PEG-PEI). Cell viability, LDH release, gene expression profiles of apoptosis-related genes and promoter activation were investigated. Interestingly, PEG-PEI, which is generally better tolerated than PEI, was found to activate apoptosis in a cell line- and concentration-dependent manner. While both polymers showed sigmoidal dose-response of cell viability in L929 cells (IC(50)(PEI) = 6 μg/ml, IC(50)(PEG-PEI) = 11 μg/ml), H1299/Luc cells exhibited biphasic dose-response for PEG-PEI and stronger apoptosis at 2 μg/ml than at 20 μg/ml PEG-PEI, as shown in TUNEL assays. Gene expression profiling confirmed that H1299/Luc cells underwent apoptosis via thousand-fold activation of TNF receptor-associated factors. Additionally, it was demonstrated that NFkB-mediated CMV promoter activation in stably transfected cells can lead to increased target gene levels after transfection instead of siRNA-mediated knockdown. With these results, polymeric vectors were shown not to be inert substances. Therefore, alterations in gene expression caused by the delivery agent must be known to correctly interpret gene-silencing experiments, to understand the mechanisms of off-target effects, and most of all to further develop vectors with reduced side effects. Taking these observations into account, one established cell line was eventually identified to be suitable for RNAi experiments. As shown by these experiments, materials that have been used for many years can elicit unexpected off-target effects. Therefore, non-viral vectors must be screened for several levels of toxicity to make them promising candidates. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183213     DOI: 10.1016/j.biomaterials.2010.11.081

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  26 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 2.  Advances in nanotechnology and asthma.

Authors:  Lingwei Wang; Mengjie Feng; Qiuwen Li; Chen Qiu; Rongchang Chen
Journal:  Ann Transl Med       Date:  2019-04

3.  Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.

Authors:  Shan Lu; Viola B Morris; Vinod Labhasetwar
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

Review 4.  Bioreducible polycations in nucleic acid delivery: past, present, and future trends.

Authors:  David Oupický; Jing Li
Journal:  Macromol Biosci       Date:  2014-03-28       Impact factor: 4.979

5.  Controlling mesenchymal stem cell gene expression using polymer-mediated delivery of siRNA.

Authors:  Danielle S W Benoit; Molly E Boutin
Journal:  Biomacromolecules       Date:  2012-10-11       Impact factor: 6.988

6.  New perspectives in nanotherapeutics for chronic respiratory diseases.

Authors:  Adriana Lopes da Silva; Fernanda Ferreira Cruz; Patricia Rieken Macedo Rocco; Marcelo Marcos Morales
Journal:  Biophys Rev       Date:  2017-09-15

7.  In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Authors:  Larissa Bueno Tofani; Lívia Vieira Depieri; Patrícia Mazureki Campos; Thalita Bachelli Riul; Kamilla Swiech Antonietto; Márcia Carvalho de Abreu Fantini; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

8.  Subcellular trafficking and transfection efficacy of polyethylenimine-polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1.

Authors:  Mikhail O Durymanov; Elena A Beletkaia; Alexey V Ulasov; Yuri V Khramtsov; Georgiy A Trusov; Nikita S Rodichenko; Tatiana A Slastnikova; Tatiana V Vinogradova; Natalia Y Uspenskaya; Eugene P Kopantsev; Andrey A Rosenkranz; Eugene D Sverdlov; Alexander S Sobolev
Journal:  J Control Release       Date:  2012-09-01       Impact factor: 9.776

9.  Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model.

Authors:  Thomas C F Bodewes; Joel M Johnson; Michael Auster; Cindy Huynh; Sriya Muralidharan; Mauricio Contreras; Frank W LoGerfo; Leena Pradhan-Nabzdyk
Journal:  FASEB J       Date:  2016-09-26       Impact factor: 5.191

10.  Suppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury.

Authors:  Huimin Yan; Xin Duan; Hua Pan; Nilsson Holguin; Muhammad Farooq Rai; Antonina Akk; Luke E Springer; Samuel A Wickline; Linda J Sandell; Christine T N Pham
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.